Cassava Sciences

+$0.37 (+0.77%) As of 3:36 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.

CEO
Remi Barbier
Employees
11
Headquarters
Austin, Texas
Founded
1998

SAVA Key Statistics

Market Cap
1.93B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.38M
High Today
$49.19
Low Today
$46.72
Open Price
$47.70
Volume
1.03M
52 Week High
$146.16
52 Week Low
$6.70

SAVA Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure